Role of Helicobacter pylori serology in screening prior to endoscopy

M. A. Mendall, P. M. Goggin, J. M. Marrero, N. Molineaux, J. Levy, S. Badve, C. Corbishley, C. Finlayson, D. Maxwell, T. C. Northfield

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Objective: To assess, prospectively, the value of a commercially available serological test for Helicobacter pylori in screening prior to endoscopy, and the effect of age and ethnic group on its performance. Design: A policy of screening by endoscopy was assessed prospectively in the direct access population. Subjects under the age of 45 years who were not taking non-steroidal anti-inflammatory drugs (NSAIDs) or who had negative serology were excluded. The most appropriate cut-off point was first determined based on the performance of the test in a clinic population, with validation against histology and biopsy urease (CLO) test. The serology used was an acid glycine extract of H. pylori. Setting: Norman Tanner Gastroenterology Unit, St George's Hospital, London, UK. Patients: Two hundred and ninety-five consecutive patients referred from clinic for endoscopy for dyspepsia and 367 consecutive patients directly referred by their general practitioner for dyspepsia. Main outcome measures: The number of patients requiring endoscopy was reduced and the percentage of pathology undetected was assessed, in the direct access population, using the cut-off point determined in the clinic population. Results: A cut-off point of 6.3 U/ml was selected as the most appropriate for screening. This resulted in a sensitivity and specificity of 98 and 75%, respectively, in the 295 clinic patients. The cut-off point at this level would have missed only one duodenal ulcer out of 22 peptic ulcers in the patients aged 45 years or under, and would have reduced the number of endoscopies in this age group by 42%. In the combined direct referral and clinic-referred populations, only two out of 38 peptic ulcers would have been missed and the number of endoscopies would then have been reduced by 41%. The performance of the test tended to improve with age in the total group of 662 patients (295 clinic and 367 direct access). In ethnic minorities, the test had a similar sensitivity but specificity was significantly reduced. Conclusion: H. pylori serology is valuable as a screening method prior to endoscopy. Age and ethnic background of patients needs to be taken into account when using serology

Original languageEnglish (US)
Pages (from-to)713-717
Number of pages5
JournalEuropean Journal of Gastroenterology and Hepatology
Volume4
Issue number9
StatePublished - Jan 1 1992

Fingerprint

Serology
Helicobacter pylori
Endoscopy
Population
Dyspepsia
Peptic Ulcer
Age Groups
Sensitivity and Specificity
Urease
Serologic Tests
Gastroenterology
Duodenal Ulcer
Ethnic Groups
Glycine
General Practitioners
Histology
Anti-Inflammatory Agents
Referral and Consultation
Outcome Assessment (Health Care)
Pathology

ASJC Scopus subject areas

  • Hepatology
  • Gastroenterology

Cite this

Mendall, M. A., Goggin, P. M., Marrero, J. M., Molineaux, N., Levy, J., Badve, S., ... Northfield, T. C. (1992). Role of Helicobacter pylori serology in screening prior to endoscopy. European Journal of Gastroenterology and Hepatology, 4(9), 713-717.

Role of Helicobacter pylori serology in screening prior to endoscopy. / Mendall, M. A.; Goggin, P. M.; Marrero, J. M.; Molineaux, N.; Levy, J.; Badve, S.; Corbishley, C.; Finlayson, C.; Maxwell, D.; Northfield, T. C.

In: European Journal of Gastroenterology and Hepatology, Vol. 4, No. 9, 01.01.1992, p. 713-717.

Research output: Contribution to journalArticle

Mendall, MA, Goggin, PM, Marrero, JM, Molineaux, N, Levy, J, Badve, S, Corbishley, C, Finlayson, C, Maxwell, D & Northfield, TC 1992, 'Role of Helicobacter pylori serology in screening prior to endoscopy', European Journal of Gastroenterology and Hepatology, vol. 4, no. 9, pp. 713-717.
Mendall MA, Goggin PM, Marrero JM, Molineaux N, Levy J, Badve S et al. Role of Helicobacter pylori serology in screening prior to endoscopy. European Journal of Gastroenterology and Hepatology. 1992 Jan 1;4(9):713-717.
Mendall, M. A. ; Goggin, P. M. ; Marrero, J. M. ; Molineaux, N. ; Levy, J. ; Badve, S. ; Corbishley, C. ; Finlayson, C. ; Maxwell, D. ; Northfield, T. C. / Role of Helicobacter pylori serology in screening prior to endoscopy. In: European Journal of Gastroenterology and Hepatology. 1992 ; Vol. 4, No. 9. pp. 713-717.
@article{47d844c9126e4ebdadb604eab8315634,
title = "Role of Helicobacter pylori serology in screening prior to endoscopy",
abstract = "Objective: To assess, prospectively, the value of a commercially available serological test for Helicobacter pylori in screening prior to endoscopy, and the effect of age and ethnic group on its performance. Design: A policy of screening by endoscopy was assessed prospectively in the direct access population. Subjects under the age of 45 years who were not taking non-steroidal anti-inflammatory drugs (NSAIDs) or who had negative serology were excluded. The most appropriate cut-off point was first determined based on the performance of the test in a clinic population, with validation against histology and biopsy urease (CLO) test. The serology used was an acid glycine extract of H. pylori. Setting: Norman Tanner Gastroenterology Unit, St George's Hospital, London, UK. Patients: Two hundred and ninety-five consecutive patients referred from clinic for endoscopy for dyspepsia and 367 consecutive patients directly referred by their general practitioner for dyspepsia. Main outcome measures: The number of patients requiring endoscopy was reduced and the percentage of pathology undetected was assessed, in the direct access population, using the cut-off point determined in the clinic population. Results: A cut-off point of 6.3 U/ml was selected as the most appropriate for screening. This resulted in a sensitivity and specificity of 98 and 75{\%}, respectively, in the 295 clinic patients. The cut-off point at this level would have missed only one duodenal ulcer out of 22 peptic ulcers in the patients aged 45 years or under, and would have reduced the number of endoscopies in this age group by 42{\%}. In the combined direct referral and clinic-referred populations, only two out of 38 peptic ulcers would have been missed and the number of endoscopies would then have been reduced by 41{\%}. The performance of the test tended to improve with age in the total group of 662 patients (295 clinic and 367 direct access). In ethnic minorities, the test had a similar sensitivity but specificity was significantly reduced. Conclusion: H. pylori serology is valuable as a screening method prior to endoscopy. Age and ethnic background of patients needs to be taken into account when using serology",
author = "Mendall, {M. A.} and Goggin, {P. M.} and Marrero, {J. M.} and N. Molineaux and J. Levy and S. Badve and C. Corbishley and C. Finlayson and D. Maxwell and Northfield, {T. C.}",
year = "1992",
month = "1",
day = "1",
language = "English (US)",
volume = "4",
pages = "713--717",
journal = "European Journal of Gastroenterology and Hepatology",
issn = "0954-691X",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - Role of Helicobacter pylori serology in screening prior to endoscopy

AU - Mendall, M. A.

AU - Goggin, P. M.

AU - Marrero, J. M.

AU - Molineaux, N.

AU - Levy, J.

AU - Badve, S.

AU - Corbishley, C.

AU - Finlayson, C.

AU - Maxwell, D.

AU - Northfield, T. C.

PY - 1992/1/1

Y1 - 1992/1/1

N2 - Objective: To assess, prospectively, the value of a commercially available serological test for Helicobacter pylori in screening prior to endoscopy, and the effect of age and ethnic group on its performance. Design: A policy of screening by endoscopy was assessed prospectively in the direct access population. Subjects under the age of 45 years who were not taking non-steroidal anti-inflammatory drugs (NSAIDs) or who had negative serology were excluded. The most appropriate cut-off point was first determined based on the performance of the test in a clinic population, with validation against histology and biopsy urease (CLO) test. The serology used was an acid glycine extract of H. pylori. Setting: Norman Tanner Gastroenterology Unit, St George's Hospital, London, UK. Patients: Two hundred and ninety-five consecutive patients referred from clinic for endoscopy for dyspepsia and 367 consecutive patients directly referred by their general practitioner for dyspepsia. Main outcome measures: The number of patients requiring endoscopy was reduced and the percentage of pathology undetected was assessed, in the direct access population, using the cut-off point determined in the clinic population. Results: A cut-off point of 6.3 U/ml was selected as the most appropriate for screening. This resulted in a sensitivity and specificity of 98 and 75%, respectively, in the 295 clinic patients. The cut-off point at this level would have missed only one duodenal ulcer out of 22 peptic ulcers in the patients aged 45 years or under, and would have reduced the number of endoscopies in this age group by 42%. In the combined direct referral and clinic-referred populations, only two out of 38 peptic ulcers would have been missed and the number of endoscopies would then have been reduced by 41%. The performance of the test tended to improve with age in the total group of 662 patients (295 clinic and 367 direct access). In ethnic minorities, the test had a similar sensitivity but specificity was significantly reduced. Conclusion: H. pylori serology is valuable as a screening method prior to endoscopy. Age and ethnic background of patients needs to be taken into account when using serology

AB - Objective: To assess, prospectively, the value of a commercially available serological test for Helicobacter pylori in screening prior to endoscopy, and the effect of age and ethnic group on its performance. Design: A policy of screening by endoscopy was assessed prospectively in the direct access population. Subjects under the age of 45 years who were not taking non-steroidal anti-inflammatory drugs (NSAIDs) or who had negative serology were excluded. The most appropriate cut-off point was first determined based on the performance of the test in a clinic population, with validation against histology and biopsy urease (CLO) test. The serology used was an acid glycine extract of H. pylori. Setting: Norman Tanner Gastroenterology Unit, St George's Hospital, London, UK. Patients: Two hundred and ninety-five consecutive patients referred from clinic for endoscopy for dyspepsia and 367 consecutive patients directly referred by their general practitioner for dyspepsia. Main outcome measures: The number of patients requiring endoscopy was reduced and the percentage of pathology undetected was assessed, in the direct access population, using the cut-off point determined in the clinic population. Results: A cut-off point of 6.3 U/ml was selected as the most appropriate for screening. This resulted in a sensitivity and specificity of 98 and 75%, respectively, in the 295 clinic patients. The cut-off point at this level would have missed only one duodenal ulcer out of 22 peptic ulcers in the patients aged 45 years or under, and would have reduced the number of endoscopies in this age group by 42%. In the combined direct referral and clinic-referred populations, only two out of 38 peptic ulcers would have been missed and the number of endoscopies would then have been reduced by 41%. The performance of the test tended to improve with age in the total group of 662 patients (295 clinic and 367 direct access). In ethnic minorities, the test had a similar sensitivity but specificity was significantly reduced. Conclusion: H. pylori serology is valuable as a screening method prior to endoscopy. Age and ethnic background of patients needs to be taken into account when using serology

UR - http://www.scopus.com/inward/record.url?scp=0026705207&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0026705207&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0026705207

VL - 4

SP - 713

EP - 717

JO - European Journal of Gastroenterology and Hepatology

JF - European Journal of Gastroenterology and Hepatology

SN - 0954-691X

IS - 9

ER -